Newsfeeds - Spark Newswire

2 minute read

Bausch + Lomb Enrolls First Patient In LASIK Clinical Trial Evaluating Use Of Technolas TENEO™ Excimer Laser For Vision Correction Surgery for Hyperopia with Astigmatism

Today, 1:10 PM

Bausch + Lomb Corporation (TSX:BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, today announced that the company has enrolled the first patient

BLCO

9 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For June 24, 2022

By Benzinga Insights

Today, 1:10 PM

Upgrades

ACB

1 minute read

Evercore ISI Group Initiates Coverage On Bausch & Lomb with Outperform Rating, Announces Price Target of $21

By Benzinga Newsdesk

Today, 1:10 PM

Evercore ISI Group analyst Vijay Kumar initiates coverage on Bausch & Lomb (NYSE:BLCO) with a Outperform rating and announces Price Target of $21.

BLCO

1 minute read

Bausch + Lomb Announces Brett Icahn And Gary Hu Have Been Appointed To Its Board Of Directors

By Benzinga Newsdesk

Today, 1:10 PM

-SEC Filing

BLCO

1 minute read

Analyst Ratings

Expert Ratings for Bausch & Lomb

By Benzinga Insights

Today, 1:10 PM

Over the past 3 months, 7 analysts have published their opinion on Bausch & Lomb (NYSE:BLCO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

BLCO

8 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 1:10 PM

On Thursday, 126 companies set new 52-week lows.

AHI

7 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For June 6, 2022

By Benzinga Insights

Today, 1:10 PM

Upgrades

ACB

1 minute read

Bausch + Lomb Announces Scientific Data On Latest Biotrue Products To Be Presented At American Optometric Association’s Optometry’s Meeting

By Benzinga Newsdesk

Today, 1:10 PM

Seven Presentations Will Include Unique Research on the New Biotrue® Hydration Plus Multi-Purpose Solution and Biotrue® Hydration Boost Lubricant Eye Drops Company to Also Host Several Sponsored Education Events

BLCO

1 minute read

Morgan Stanley Initiates Coverage On Bausch & Lomb with Equal-Weight Rating, Announces Price Target of $22

By Benzinga Newsdesk

Today, 1:10 PM

Morgan Stanley analyst Cecilia Furlong initiates coverage on Bausch & Lomb (NYSE:BLCO) with a Equal-Weight rating and announces Price Target of $22.

BLCO

3 minute read

The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton’s Partnered Epilepsy Drug, ASCO Conference Gets Underway And More

By Shanthi Rexaline

Today, 1:10 PM

Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for the year-to-date period.

ABBV